homocysteine has been researched along with pioglitazone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HF; Lu, JM; Ma, FL; Pan, CY; Yang, GQ; Zou, XM | 1 |
| Hasegawa, K; Hayashi, K; Homma, K; Kanda, T; Saruta, T; Sugano, N; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
| Falcone, JC; Fleming, JT; Joshua, IG; Passmore, JC; Rodriguez, WE; Tyagi, N; Tyagi, SC | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Gravina, A; Montagna, L; Paniga, S; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Cao, J; Jiang, Y; Li, G; Wang, S; Xiong, J; Zhang, J | 1 |
| Gao, PJ; Li, L; Lu, GP; Wu, CF; Xi, R; Yan, J; Zhu, DL | 1 |
| Takemoto, M; Yokote, K | 1 |
| Nagaoka, T; Omae, T; Tanano, I; Yoshida, A | 1 |
| Li, Q; Wang, M; Xu, S; Yu, L; Zhao, Y; Zhu, J | 1 |
1 review(s) available for homocysteine and pioglitazone
| Article | Year |
|---|---|
[Prevention, treatment and management of inflammation in atherosclerosis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Biomarkers; C-Reactive Protein; Chronic Disease; Diet, Reducing; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney Diseases; Lipoprotein(a); Lipoproteins, LDL; Metabolic Syndrome; Oxidative Stress; Pioglitazone; Risk Factors; Smoking Cessation; Thiazolidinediones | 2011 |
1 trial(s) available for homocysteine and pioglitazone
| Article | Year |
|---|---|
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Metformin; Middle Aged; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2006 |
7 other study(ies) available for homocysteine and pioglitazone
| Article | Year |
|---|---|
[The impact of pioglitazone on plasma homocysteine high-fat diet-induced insulin resistance in rats].
Topics: Animals; Blood Glucose; Dietary Fats; Homocysteine; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2005 |
Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Topics: Amidohydrolases; Animals; Arginine; Cell Line; Dogs; Enzyme Induction; Gene Expression Regulation, Enzymologic; Homocysteine; Hypoglycemic Agents; Kidney Tubules; Male; Nitric Oxide; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Sodium; Thiazolidinediones; Up-Regulation | 2005 |
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
Topics: Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fats; Hemodynamics; Homocysteine; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phenylephrine; Pioglitazone; Thiazolidinediones | 2006 |
Ligands of peroxisome proliferator-activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene.
Topics: Azo Compounds; Base Sequence; Clofibrate; DNA Methylation; DNA Modification Methylases; DNA Primers; Foam Cells; Homocysteine; Humans; Ligands; Molecular Sequence Data; Monocytes; Nitric Oxide Synthase Type II; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Thiazolidinediones | 2007 |
Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Topics: Animals; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Homocysteine; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2008 |
Homocysteine inhibition of endothelium-dependent nitric oxide-mediated dilation of porcine retinal arterioles via enhanced superoxide production.
Topics: Animals; Arterioles; Bradykinin; Calcimycin; Endothelium, Corneal; Homocysteine; Hypoglycemic Agents; NADPH Oxidases; Nitric Oxide; Pioglitazone; PPAR gamma; Protein Kinase Inhibitors; Protein Kinases; Retinal Artery; Superoxides; Swine; Thiazolidinediones; Vasodilation; Xanthine Oxidase | 2013 |
Pioglitazone restores the homocysteine‑impaired function of endothelial progenitor cells via the inhibition of the protein kinase C/NADPH oxidase pathway.
Topics: Cell Adhesion; Cell Movement; Diffusion Chambers, Culture; Endothelial Progenitor Cells; Gene Expression Regulation; Homocysteine; Humans; Hypoglycemic Agents; NADPH Oxidase 2; Phosphoproteins; Pioglitazone; PPAR gamma; Primary Cell Culture; Protein Kinase C; Reactive Oxygen Species; Signal Transduction; Thiazolidinediones | 2018 |